Login Register Cart 0
Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Mitochondrial Medicine for Neurological Disorders

Author(s): Md. Sahab Uddin, Badrah S. Alghamdi and Ghulam Md. Ashraf*

Volume 21, Issue 5, 2023

Published on: 20 March, 2023

Page: [1024 - 1025] Pages: 2

DOI: 10.2174/1570159X2105230320095644

Price: $65

« Previous Next »
[1]
Sheikh, A.S.; Hao, W.; Muhammad, S.; Summar, S.; Muhammad, A.; Gulnaz, P.; Mehreen, R.; Muhammad, S.K.; Muhammad, N.I.; Abbeha, M. Pharmacological progress of mitophagy regulation. Curr. Neuropharmacol., 2023, 21(5), 1026-1041.
[2]
Khan, M.M.; Paez, H.G.; Pitzer, C.R.; Always, S.E. The therapeutic potential of mitochondria transplantation therapy in neurodegenerative and neurovascular disorders. Curr. Neuropharmacol., 2023, 21(5), 1100-1116.
[http://dx.doi.org/10.2174/1570159X05666220908100545] [PMID: 36089791]
[3]
Dhasmana, S.; Dhasmana, A.; Kotnala, S.; Mangtani, V.; Narula, A.S.; Haque, S.; Jaggi, M.; Yallapu, M.M.; Chauhan, S.C. Boosting mitochondrial potential: An imperative therapeutic intervention in Amyotrophic lateral sclerosis. Curr. Neuropharmacol., 2023, 21(5), 1117-1138.
[http://dx.doi.org/10.2174/1570159X20666220915092703] [PMID: 36111770]
[4]
Mominur, Md. R.; Mst. Afroza, A.T.; Md. Saidur, R.; Fahadul, I.; Popy, R.S.; Muniruddin, A.; Badrah, S.A.; Abdul, H.; Athanasios, A.; Asma, P.; and Ghulam, M.A. Emerging promise of the therapeutic approaches of mitochondria for neurodegenerative disorders. Curr. Neuropharmacol., 2023, 21(5), 1081-1099.
[5]
Gareev, I.; Beylerli, O.; Liang, Y.; Lu, E.; Ilyasova, T.; Sufianov, A.; Sufianova, G.; Shi, H.; Ahmad, A.; Yang, G. The role of mitochondria-targeting miRNAs in intracerebral hemorrhage. Curr. Neuropharmacol., 2023, 21(5), 1065-1080.
[http://dx.doi.org/10.2174/1570159X20666220507021445] [PMID: 35524670]
[6]
Nabi, S.U.; Rehman, M.U.; Arafah, A.; Taifa, S.; Khan, I.S.; Khan, A.; Rashid, S.; Jan, F.; Wani, H.A.; Ahmad, S.F. Treatment of Autism Spectrum disorders by mitochondrial-targeted drug: Future of neurological diseases therapeutics. Curr. Neuropharmacol., 2023, 21(5), 1042-1064.
[http://dx.doi.org/10.2174/1570159X21666221121095618] [PMID: 36411568]
[7]
Kundu, S.; Singh, S. What happens in TBI? A wide talk on animal models and future per-spective. Curr. Neuropharmacol., 2023, 21(5), 1139-1164.
[http://dx.doi.org/10.2174/1570159X20666220706094248] [PMID: 35794772]
[8]
Almikhlafi, M.A.; Karami, M.M.; Jana, A.; Alqurashi, T.M.; Majrashi, M.; Alghamdi, B.S.; Ashraf, G.M. Mitochondrial medicine: A promising therapeutic option against various neurodegenera-tive disorders. Curr. Neuropharmacol., 2023, 21(5), 1165-1183.
[http://dx.doi.org/10.2174/1570159X20666220830112408] [PMID: 36043795]
[9]
Shaito, A.; Al-Mansoob, M.; Ahmad, S.M.S.; Haider, M.Z.; Eid, A.H.; Posadino, A.M.; Pintus, G.; Giordo, R. Resveratrol-mediated regulation of mitochondria biogenesis-associated path-ways in neurodegenerative diseases: molecular insights and potential therapeutic applications. Curr. Neuropharmacol., 2023, 21(5), 1184-1201.
[http://dx.doi.org/10.2174/1570159X20666221012122855] [PMID: 36237161]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy